Randomized Adaptive Platform Trial of Pathogen-Directed Anti-inflammatory Therapy in Severe Community-Acquired Pneumonia(Core Protocal)
Clinical trial NCT07152587 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07152587
- Sponsor
- Qingyuan Zhan
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-08
- Primary completion
- 2035-12-31
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.